20/20 Biolabs COO granted 150,000 stock options
20/20 Biolabs, Inc. Chief Operating Officer Zhou Jiming received a grant of stock options covering 150,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
20/20 Biolabs, Inc. Chief Operating Officer Zhou Jiming received a grant of stock options covering 150,000 shares of Common Stock. The options have an exercise price of $1.88 per share, were granted on April 2, 2026, and expire on April 2, 2036. Following this grant, Zhou holds 150,000 stock options directly.
Insider Trade Summary
Grant/Award: 150,000 shares
Grant/Award
1 txn
Insider
Zhou Jiming
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 150,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 150,000 contracts (Direct)
Key Figures
Options granted: 150,000 options
Exercise price: $1.88 per share
Expiration date: April 2, 2036
+2 more
5 metrics
Options granted
150,000 options
Stock option grant to COO on April 2, 2026
Exercise price
$1.88 per share
Exercise price of granted stock options
Expiration date
April 2, 2036
Option term for 150,000 granted options
Options owned after grant
150,000 options
Total stock options directly held following transaction
Transaction price per option
$0.00
Reported transaction price per option in grant
Key Terms
Stock Option, exercise price, expiration date, Common Stock, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "1.8800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-04-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did 20/20 Biolabs (AIDX) COO Zhou Jiming report in this Form 4?
Zhou Jiming reported receiving a grant of stock options for 150,000 shares of 20/20 Biolabs Common Stock. The options were awarded on April 2, 2026, giving him the right to buy shares at a fixed exercise price in the future before expiration.
How many 20/20 Biolabs (AIDX) stock options were granted to Zhou Jiming?
The filing shows a grant of stock options covering 150,000 shares of 20/20 Biolabs Common Stock. This entire amount is reported as directly owned following the transaction, indicating Zhou’s option position from this grant totals 150,000 shares.
What is the exercise price of the stock options granted to 20/20 Biolabs (AIDX) COO?
The stock options have an exercise price of $1.88 per share. This means Zhou can choose to purchase 20/20 Biolabs Common Stock at $1.88 for each optioned share during the option term, regardless of the market price at that time.
When do Zhou Jiming’s 20/20 Biolabs (AIDX) stock options expire?
The options expire on April 2, 2036, according to the Form 4. Until that expiration date, Zhou holds the right, but not the obligation, to exercise these options at the fixed $1.88 per share exercise price for the 150,000 underlying shares.
Is the 20/20 Biolabs (AIDX) Form 4 transaction a purchase or a grant?
The transaction is classified as a grant or award acquisition of stock options, not an open-market share purchase. The Form 4 uses transaction code “A” and describes it as a grant, reflecting compensation-related option issuance rather than a market trade.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates